Kemnay Advisory Services’s Gilead Sciences GILD Stock Holding History

Kemnay Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.7K	Buy	500 +6	+1%	+$840	0.01%	188
2025 Q4	$60.6K	Buy	+494	New	+$60K	0.01%	273
2021 Q3	–	Sell	-11,669	Closed	-$804K	–	101
2021 Q2	$804K	Buy	+11,669	New	+$779K	0.1%	59

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Kemnay Advisory Services's GILD Position: Q1 2026 in Review

Kemnay Advisory Services increased its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, buying an estimated $840 and bringing the position to 500 shares worth $69.7K. The position accounts for 0.01% of the portfolio, ranked #188.

Kemnay Advisory Services first reported a position in GILD in Q2 2021 and has held it in 3 quarters since. The position peaked at $804K in Q2 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Kemnay Advisory Services held 500 shares of Gilead Sciences worth $69.7K as of Q1 2026.
Kemnay Advisory Services bought 6 Gilead Sciences shares in Q1 2026, an estimated $840.
Gilead Sciences made up 0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #188 holding.
Kemnay Advisory Services first reported a position in Gilead Sciences in Q2 2021 and has held it in 3 quarters since.
Kemnay Advisory Services's Gilead Sciences position peaked at $804K in Q2 2021.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.